의약품 관련 법령
Expedited Programs for Regenerative Medicine Therapies for Serious Conditions
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2019-02-15 | 조회수 | 1,162 |
국가정보 | 북 아메리카>미국 | ||
출처 | FDA | ||
원문 | https://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/cellularandgenetherapy/ucm585414.pdf | ||
첨부파일 |
Expedited Programs for Regenerative Medicine Therapies for Serious Conditions
- 이전글 Immunogenicity Testing of Therapeutic Protein Products - Developing and Validating Assays for Anti-Drug Antibody Detection
- 다음글 REMS Assessment: Planning and Reporting